Citations Report

Articles published in Clinical Schizophrenia & Related Psychoses have been cited by esteemed scholars and scientists all around the world. Clinical Schizophrenia & Related Psychoses has got h-index 41, which means every article in Clinical Schizophrenia & Related Psychoses has got 41 average citations.

Following are the list of articles that have cited the articles published in Clinical Schizophrenia & Related Psychoses.

van Beveren, Nico JM, Nuray Çakici, and Iris E. Sommer. "Anti-inflammatory Agents for Patients with Schizophrenia." In Immuno-Psychiatry, pp. 365-388. Springer, Cham, 2021.

Buswell, Georgina, Zoë Haime, Brynmor Lloyd-Evans, and Jo Billings. "A systematic review of PTSD to the experience of psychosis: prevalence and associated factors." BMC psychiatry 21, no. 1 (2021): 1-13.

Zhuo, Chuanjun, Yong Xu, Haibo Wang, Tao Fang, Jiayue Chen, Chunhua Zhou, Qianchen Li et al. "Safety and Efficacy of High-Dose Vitamin B6 as an Adjunctive Treatment for Antipsychotic-Induced Hyperprolactinemia in Male Patients With Treatment-Resistant Schizophrenia." Frontiers in psychiatry 12 (2021).

ÓConghaile, Aengus, Diane L. Smedberg, Ah L. Shin, and Lynn E. DeLisi. "Familial risk for psychiatric disorders in military veterans who have post-traumatic stress disorder with psychosis: A retrospective electronic record review." Psychiatric genetics 28, no. 2 (2018): 24-30.

Renkema, Tristan C., Lieuwe De Haan, Frederike Schirmbeck, Behrooz Z. Alizadeh, Therese van Amelsvoort, Agna A. Bartels-Velthuis, Nico J. van Beveren et al. "Childhood trauma and coping in patients with psychotic disorders and obsessive-compulsive symptoms and in un-affected siblings." Child abuse & neglect 99 (2020): 104243.

Zhuo, Chuanjun, Yong Xu, Haibo Wang, Tao Fang, Jiayue Chen, Chunhua Zhou, Qianchen Li et al. "Safety and Efficacy of High-Dose Vitamin B6 as an Adjunctive Treatment for Antipsychotic-Induced Hyperprolactinemia in Male Patients With Treatment-Resistant Schizophrenia." Frontiers in psychiatry 12 (2021).

Weiden, Peter J., Amy Claxton, Jelena Kunovac, David P. Walling, Yangchun Du, Baiyun Yao, Sergey Yagoda, Ilda Bidollari, Elizabeth Keane, and Ethan Cash. "Efficacy and safety of a 2-month formulation of aripiprazole lauroxil with 1-day initiation in patients hospitalized for acute schizophrenia transitioned to outpatient care: phase 3, randomized, double-blind, active-control ALPINE Study." The Journal of Clinical Psychiatry 81, no. 3 (2020): 0-0.

Dallel, Samy, Aida Cancel, and Eric Fakra. "Prevalence of posttraumatic stress disorder in schizophrenia spectrum disorders: A systematic review." (2018): 1027-1037.

Fornells-Ambrojo, Miriam, Alison Gracie, Chris R. Brewin, and Amy Hardy. "Narrowing the focus on the assessment of psychosis-related PTSD: a methodologically orientated systematic review." European journal of psychotraumatology 7, no. 1 (2016): 32095.

Rodrigues, Rebecca, and Kelly K. Anderson. "The traumatic experience of first-episode psychosis: a systematic review and meta-analysis." Schizophrenia research 189 (2017): 27-36.

Si, Tianmei, Jianmin Zhuo, Ibrahim Turkoz, Maju Mathews, Wilson Tan, and Yu Feng. "Once-monthly injection of paliperidone palmitate in patients with recently diagnosed and chronic schizophrenia: a post-hoc comparison of efficacy and safety." Expert opinion on pharmacotherapy 18, no. 17 (2017): 1799-1809.

de Filippis, Renato, Pasquale De Fazio, Raffaele Gaetano, Luca Steardo, Clemente Cedro, Antonio Bruno, Rocco Antonio Zoccali, and Maria Rosaria Anna Muscatello. "Current and emerging long-acting antipsychotics for the treatment of schizophrenia." Expert Opinion on Drug Safety (2021): 1-20.

Grigorov, Hristo S. "Oestrogen (adjunct) versus placebo for women with schizophrenia." (2016).

Kim, Edward, Christoph U. Correll, Lian Mao, H. Lynn Starr, and Larry Alphs. "Once-monthly paliperidone palmitate compared with conventional and atypical daily oral antipsychotic treatment in patients with schizophrenia." CNS spectrums 21, no. 6 (2016): 466-477.

González-Rodríguez, Alexandre, Armand Guàrdia, and José Antonio Monreal. "Peri-and Post-Menopausal Women with Schizophrenia and Related Disorders Are a Population with Specific Needs: A Narrative Review of Current Theories." Journal of Personalized Medicine 11, no. 9 (2021): 849.

Sigfridsson, Kalle, Torbjörn Arvidsson, Aixiang Xue, David J. Wagner, Petar Pop-Damkov, Guangnong Zhang, and Marie Strimfors. "A candidate drug administered subcutaneously to rodents as drug particles showing hepatic recirculation which influenced the sustained release process." International journal of pharmaceutics 581 (2020): 119252.

Tchobaniouk, Lesia V., Erin E. McAllister, Danielle L. Bishop, Rachel M. Carpentier, Katharine R. Heins, Robert J. Haight, and Jeffrey R. Bishop. "Once-Monthly Subcutaneously Administered Risperidone in the Treatment of Schizophrenia: Patient Considerations." Patient preference and adherence 13 (2019): 2233.

Emsley, Robin, and Sanja Kilian. "Efficacy and safety profile of paliperidone palmitate injections in the management of patients with schizophrenia: an evidence-based review." Neuropsychiatric disease and treatment 14 (2018): 205.

Krogmann, Amanda, Luisa Peters, Laura Von Hardenberg, Katja Bödeker, Viktor B. Nöhles, and Christoph U. Correll. "Keeping up with the therapeutic advances in schizophrenia: a review of novel and emerging pharmacological entities." CNS spectrums 24, no. S1 (2019): 38-69.

Rubin, Leah H. "Understanding sex differences in psychosis through the exploration of hormonal contributions." (2021).